Catheter Precision Past Earnings Performance
Past criteria checks 0/6
Catheter Precision's earnings have been declining at an average annual rate of -40.4%, while the Medical Equipment industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 108.6% per year.
Key information
-40.4%
Earnings growth rate
112.9%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 108.6% |
| Return on equity | -333.0% |
| Net Margin | -16,147.5% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Catheter Precision makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 0 | -71 | 17 | 0 |
| 30 Sep 23 | 0 | -79 | 22 | 1 |
| 30 Jun 23 | 0 | -82 | 23 | 1 |
| 31 Mar 23 | 0 | -89 | 24 | 4 |
| 31 Dec 22 | 0 | -27 | 16 | 6 |
| 30 Sep 22 | 0 | -27 | 12 | 10 |
| 30 Jun 22 | 0 | -30 | 13 | 12 |
| 31 Mar 22 | 0 | -26 | 14 | 13 |
| 31 Dec 21 | 0 | -27 | 15 | 12 |
| 30 Sep 21 | 0 | -29 | 18 | 12 |
| 30 Jun 21 | -2 | -29 | 17 | 11 |
| 31 Mar 21 | -1 | -34 | 22 | 10 |
| 31 Dec 20 | 0 | -35 | 25 | 9 |
Quality Earnings: VTAK is currently unprofitable.
Growing Profit Margin: VTAK is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if VTAK's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare VTAK's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VTAK is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).
Return on Equity
High ROE: VTAK has a negative Return on Equity (-333%), as it is currently unprofitable.